ClinicalTrials.govpublic full text
Anti-Inflammatory Effects of Rosiglitazone in Patients With Stage 4 and 5 Chronic Kidney Disease
chronic kidney disease, inflammation, interventional, phase2, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 872635
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.